| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |